| OPMDs | Oral potentially malignant disorders |
| OSCC | Oral squamous cell carcinoma |
| Cf-DNA | Cell-free DNA |
| Ct-DNA | Circulating tumor DNA |
| OLK | Oral leukoplakia |
| OLP | Oral lichen planus |
| OSF | Oral submucous fibrosis |
| CSF | Cerebrospinal fluid |
| HNSCC | Head and Neck Squamous Cell Carcinoma |
| ddPCR | Droplet digital polymerase chain reaction |
| WES | Whole-exome sequencing |
| MRD | Minimal residual disease |
| dPCR | Digital PCR |
| TME | Tumor microenvironment |
| MS | Mass spectrometry |
| iTRAQ | Isobaric tags for relative and absolute quantitation |
| LC-MRM/MS | Liquid Chromatography Multiple-Reaction-Monitoring Mass Spectrometry |
| MALDI-MSI | Matrix-assisted laser desorption/ionization mass spectrometry imaging |
| SELDI-TOF/MS | Surface-enhanced laser desorption/ionization-time-of-flight/mass spectrometry |
| CFH | Complement factor H |
| FGA | Fibrinogen alpha chain |
| SERPINA1 | Alpha-1-antitrypsin |
| GC-MS | Gas chromatography–mass spectrometry |
| UHPLC-MS/MS | Ultra-high-performance liquid chromatography–tandem mass spectrometry |
| CE-MS | Capillary electrophoresis-mass spectrometry |
| NMR | Nuclear magnetic resonance |